Monosol Rx, LLC

Fuisz Technologies Ltd.

Other

Aquestive Therapeutics, Inc.

Biovail Technologies Ltd.

Robert K Yang

Richard C Fuisz

Garry L Myers

Joseph M Fuisz

Subraman R Cherukuri

Gary L Myers

Jose F Zamudio-Tena

Mark R Herman

Andrea S Blake

Chi-Neng Arthur Han

Alex J Phinn

T Victor Oh

Whitney S Cavanagh

Paul M Croushorn

Santi R Bhowmik

Cecil A Bowles

Steven E Frisbee

Claude Bayard

Tommy L Chau

John R Sisak

Supapong Siris

Suresh B Kota

Peter King

Matthew J Strait

Martin K Schaller

Bei Zhang

Francisco Zamudio-Tena

David M Teale

Richard C Fuiz

Andrea S Brothers

Sambasiva Ghanta

Joseph M Fuiz

Amrik Khurana

Abhijit Banerjee

The invention relates to the film products and methods of their preparation that demonstrate a non-self-aggregating uniform heterogeneity. Desirably, the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film. The films contain a polymer component, which includes polyethylene oxide optionally blended with hydrophilic cellulosic polymers. Desirably, the films also contain a pharmaceutical and/or cosmetic active agent with no more than a 10% variance of the active agent pharmaceutical and/or cosmetic active agent per unit area of the film.

Process for manufacturing a resulting pharmaceutical film

The invention relates to film products containing desired levels of active components and methods of their preparation. Desirably, the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film. Desirably, the films may be exposed to temperatures above that at which the active components typically degrade without concern for loss of the desired activity.

Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom

The present invention relates to products and methods for treatment of various symptoms in a patient, including treatment of pain suffered by a patient. The invention more particularly relates to self-supporting dosage forms which provide an active agent while providing sufficient buccal adhesion of the dosage form. Further, the present invention provides a dosage form which is useful in reducing the likelihood of diversion abuse of the active agent.

Sublingual and buccal film compositions

The present invention relates to rapid dissolve thin film drug delivery compositions for the oral administration of active components. The active components are provided as taste-masked or controlled-release coated particles uniformly distributed throughout the film composition. The compositions may be formed by wet casting methods, where the film is cast and controllably dried, or alternatively by an extrusion method.

Uniform films for rapid dissolve dosage form incorporating taste-masking compositions

Process for manufacturing a resulting multi-layer pharmaceutical film

Process for making a film having a substantially uniform distribution of components

The invention relates to the film products and methods of their preparation that demonstrate a non-self-aggregating uniform heterogeneity. Desirably the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film.

Polyethylene oxide-based films and drug delivery systems made therefrom

Polyethylene-oxide based films and drug delivery systems made therefrom

Growing community of inventors

Flushing, NY, United States of America

Robert K Yang